Severe inhibitor-negative acquired factor XIII/13 deficiency with aggressive subdural haemorrhage

Hiroki Kawano, Daisuke Yamamoto, Yoshito Uchihashi, Kanako Wakahashi, Yuko Kawano, Akiko Sada, Kentaro Minagawa, Yoshio Katayama, Eiji Kohmura, Masayoshi Souri, Akitada Ichinose

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Acquired factor XIII (FXIII) deficiency is a common disease and seldom causes bleeding. However, severe FXIII deficiency may result in life-threatening bleeding. Although the inhibitor against FXIII has recently been focused as the cause of haemorrhagic acquired FXIII deficiency, the pathophysiology of inhibitor-negative cases could also be involved. We report a case of an 85-year-old Japanese man with serious subdural haemorrhage showing a remarkable decreased level of FXIII activity. He also manifested complications of compensated disseminated intravascular coagulation (DIC) with chronic renal failure, abdominal aortic aneurysm (AAA) and right renal carcinoma. Despite the successful evacuation of the haemorrhage, acute subdural haemorrhage subsequently developed that necessitated further craniotomies. Plasma cross-mixing studies and dot blot assay revealed no inhibitors against FXIII. We speculated that the decreased FXIII activity could be mainly due to hyperconsumption by DIC and surgery. Because plasma-derived FXIII concentrates are available to stop bleeding, clinicians should be aware of severe acquired inhibitor-negative FXIII deficiency in cases of unexplained excessive bleeding.

Original languageEnglish (US)
Pages (from-to)638-641
Number of pages4
JournalBlood Coagulation and Fibrinolysis
Issue number6
StatePublished - Sep 2013

All Science Journal Classification (ASJC) codes

  • Hematology


Dive into the research topics of 'Severe inhibitor-negative acquired factor XIII/13 deficiency with aggressive subdural haemorrhage'. Together they form a unique fingerprint.

Cite this